Literature DB >> 8574213

Adverse reaction to streptokinase with multiple systemic manifestations.

I Montserrat1, J Altimiras, M Dominguez, R Lamich, A Ollé, J Fontcuberta.   

Abstract

We report the case of a 47-year-old woman with a history of mitral valve replacement with a mechanical prosthesis who was admitted to the hospital with a 3-month history of progressive exertional dyspnoea and was diagnosed as suffering from prosthetic valve thrombosis. Two consecutive courses of streptokinase were given as an intravenous infusion over 90 min at a dose of 1,500,000 IU each. Twenty minutes after the start of the second infusion (3 h and 20 min after the first one) she developed chills, fever, tachycardia and hypotension: symptomatic treatment was given and the infusion was completed. Two days later jaundice and choluria appeared with laboratory findings of hepatic cytolysis and cholestasis and renal insufficiency. The results of extensive microbiological and immunological investigations were not revealing. All the laboratory values spontaneously returned to baseline levels over the next 4 weeks. These abnormalities were attributed to an allergic reaction to streptokinase, although the exact pathogenic mechanisms involved are not known. We believe that further studies to elucidate the mechanism involved in the production of these effects are warranted in view of their potential clinical severity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8574213     DOI: 10.1007/bf01879712

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  16 in total

1.  Activities of aminotransferases after treatment with streptokinase for acute myocardial infarction.

Authors:  A C Maclennan; N Ahmad; J R Lawrence
Journal:  BMJ       Date:  1990-08-11

2.  Hepatic dysfunction induced by streptokinase.

Authors:  M I Polkey; R M Oliver; J M Walker
Journal:  Am J Gastroenterol       Date:  1992-08       Impact factor: 10.864

3.  Transient impairment of renal function after streptokinase therapy.

Authors:  S T Payne; H S Hosker; M B Allen; H Bradbury; R L Page
Journal:  Lancet       Date:  1989-12-09       Impact factor: 79.321

4.  Allergic reactions to streptokinase consistent with anaphylactic or antigen-antibody complex-mediated damage.

Authors:  K G McGrath; B Zeffren; J Alexander; K Kaplan; R Patterson
Journal:  J Allergy Clin Immunol       Date:  1985-09       Impact factor: 10.793

5.  Anaphylaxis.

Authors:  A L Sheffer
Journal:  J Allergy Clin Immunol       Date:  1985-02       Impact factor: 10.793

6.  Successful treatment of prosthetic heart-valve thrombosis with high short-term doses of streptokinase.

Authors:  F Ortuño; J Fontcuberta; G Pons-Llaurado; I Montserrat; M Cladellas; J M Llobet; E Grau
Journal:  Lancet       Date:  1988-09-10       Impact factor: 79.321

7.  Streptokinase-induced hepatic dysfunction.

Authors:  M K Sallen; M E Efrusy; J L Kniaz; P M Wolfson
Journal:  Am J Gastroenterol       Date:  1983-08       Impact factor: 10.864

8.  Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).

Authors: 
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

9.  Anaphylactic reactivity to streptokinase.

Authors:  K G McGrath; R Patterson
Journal:  JAMA       Date:  1984-09-14       Impact factor: 56.272

Review 10.  Anaphylactic reaction to streptokinase with first exposure: case report and review of the literature.

Authors:  E M Bednarczyk; S C Sherlock; M G Farah; J A Green
Journal:  DICP       Date:  1989-11
View more
  1 in total

1.  [Complications of venous port systems : Radiological diagnostics and minimally invasive therapy].

Authors:  N Rathmann; D Hausmann; M Kostrzewa; M Keese; S Diehl; S Schönberg; M Sadick
Journal:  Radiologe       Date:  2011-05       Impact factor: 0.635

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.